文献速递病毒性肝炎

全自动深度测序平台用于乙型肝炎基因分型及耐药检测的性能评估

Performance evaluation of a fully automated deep sequencing platform for hepatitis B genotyping and resistance testing.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

该研究评估基于深度测序的ViroKey® SQ FLEX基因分型试剂盒检测HBV基因型及耐药谱的性能,将慢性乙型肝炎患者血浆样本分别用Sanger测序和深度测序检测,发现两者一致性高,且深度测序检测次要变异株更敏感,结论认为该深度测序试剂盒可自信用于临床HBV基因分型和耐药检测。

要点

  • 与群体测序相比,深度测序平台在检测HBV基因型和耐药突变上具有高度一致性。
  • 深度测序在检测次要变异群体方面比群体测序更敏感。
  • 作者认为该深度测序试剂盒可自信用于临床HBV基因分型和耐药检测。

核心结论

  • 基于深度测序的ViroKey® SQ FLEX基因分型试剂盒可自信用于临床实践中的乙型肝炎基因分型和耐药检测。

研究设计与样本

  • 研究纳入慢性乙型肝炎患者的血浆样本,分别采用Sanger(群体)测序(覆盖P/S重叠基因的一部分)和基于深度测序的ViroKey® SQ FLEX基因分型试剂盒(Vela Diagnostics)进行测序。

主要发现

  • 无论HBV基因型如何,深度测序与群体测序均显示出高度一致性。
  • 使用Sentosa平台的深度测序在检测次要变异群体方面比群体测序更敏感。

临床怎么用

  • 作者认为该深度测序试剂盒可自信用于临床实践中的乙型肝炎基因分型和耐药检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of chronic hepatitis B infection requires lifelong administration of nucleos(t)ide analogues with a high barrier to resistance and effective viral suppression. The major limitation of lifelong therapy is the possible selection of drug-resistant hepatitis B virus (HBV) strains. International Liver Society guidelines recommend that hepatitis B resistance testing must be performed by a reference laboratory. OBJECTIVES: Performance of the deep sequencing-based ViroKey® SQ FLEX Genotyping Assay for the determination of HBV genotypes and resistance profiles were evaluated. PATIENTS AND METHODS: Plasma samples collected from patients with chronic hepatitis B have been sequenced by two methods including Sanger (population) sequencing of a portion of the P/S overlapping gene and the deep sequencing-based ViroKey® SQ FLEX Genotyping Assay (Vela Diagnostics). RESULTS: A high concordance rate with population sequencing was found regardless of HBV genotypes. Deep sequencing with the Sentosa platform was more sensitive than population sequencing in detecting minor variant populations. CONCLUSIONS: The deep sequencing-based ViroKey® SQ FLEX Genotyping Assay can be confidently used in clinical practice for hepatitis B genotyping and resistance testing.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Ortonne V, Bouvier-Alias M, Vo-Quang E, et al. Performance evaluation of a fully automated deep sequencing platform for hepatitis B genotyping and resistance testing. J Antimicrob Chemother. 2025. PMID: 39918840. doi:10.1093/jac/dkae418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。